IHS Chemical Week

People & Business :: M&A

Amgen and Astellas form biopharmaceuticals joint venture in Japan

9:28 AM MDT | May 29, 2013 | Natasha Alperowicz

Amgen (Thousand Oaks, CA), the world's largest independent biotechnology company; and Astellas Pharma (Tokyo), a leading pharmaceutical company, have entered into a strategic alliance to provide new medicines to help address serious unmet medical needs of Japanese patients, the companies announced today.   The alliance leverages the complementary capabilities of both companies through an innovative business model that combines Amgen's pipeline candidates with Astellas's knowledge of Japanese patient and physician needs, long-term commercial and regulatory...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.



Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.

 














 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa